Evidence map›Paper›PMID 34294467›Full record

ArticleJournal of molecular biology2021

Corrigendum to "Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modified Kinase and GTP-binding Activities" [J. Mol. Biol. 412(1) (2011) 94-110].

Philip J Webber, Archer D Smith, Saurabh Sen, Matthew B Renfrow, James A Mobley, Andrew B West

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Philip J WebberDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA; Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Archer D SmithDepartment of Surgery, University of Alabama at Birmingham, Birmingham, AL 35294, USA; Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA; UAB Laboratory for Biomedical FT-ICR Mass Spectrometry, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Saurabh SenDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA; Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Matthew B RenfrowDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA; UAB Laboratory for Biomedical FT-ICR Mass Spectrometry, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
James A MobleyDepartment of Surgery, University of Alabama at Birmingham, Birmingham, AL 35294, USA; Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA; UAB Laboratory for Biomedical FT-ICR Mass Spectrometry, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Andrew B WestDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA; Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Electronic address: Andrew.West@Duke.edu.

Funding

The Role of LRRK2 in the Pathogenesis of Parkinson's DiseaseR00NS058111 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WEST, ANDREW B · 2008 to 2010
$722k
NINDS NIH HHS R00 NS058111
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34294467
PMCPMC8381384

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.